Earnings Preview: VolitionRX
Portfolio Pulse from Benzinga Insights
VolitionRX (AMEX:VNRX) is scheduled to release its quarterly earnings report on Tuesday, 2023-11-14, with analysts expecting an EPS of $-0.13. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, VolitionRX's stock price has shown mixed reactions to past earnings performances. The stock is currently trading at $0.8799, down 51.87% over the last 52 weeks. Shareholders are likely concerned as they approach this earnings release.
November 13, 2023 | 5:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
VolitionRX is expected to report an EPS of $-0.13 for the latest quarter. Past earnings have led to mixed stock price reactions. The stock has declined 51.87% over the past year, indicating potential investor concern ahead of the earnings release.
The expected EPS is a key indicator of the company's performance, and while an earnings beat could positively influence the stock price, the historical mixed reactions suggest a neutral short-term impact. The long-term downward trend in stock price may temper any positive reaction to an earnings beat.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100